Semler Scientific, an emerging medical risk-assessment company, has appointed Aidan Collins to the company's board of directors and as chairman of the audit committee.
With an extensive career in healthcare risk management and business development, Collins brings a wide range of expertise in strategic, operational and financial management to the Semler team.
Semler’s mission is to develop, manufacture and market patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services.
"Aidan's experience in developing analytical tools for managing operational risk for healthcare companies and improving operations, including cost reduction, is critical for Semler's development," said Dr Doug Murphy-Chutorian, chief executive officer of Semler. "His leadership skills in business development will also be greatly beneficial as we identify and implement growth opportunities for our company."
Collins currently serves as the chief executive officer and founder of ControlMetric, a consulting and software company focused on bringing data-driven, fact-based approaches to operational risk management. .
Prior to ControlMetric, Mr. Collins served as a partner at Bain & Company, from 2007 to 2010, where he led client relationships and consulting projects covering a range of strategic and operations issues, including IT strategy, cost reduction, post-merger integration and operations improvement.
Semler Scientific, Aidan Collins, US
